MoneyWorks4Me

Kimia Biosciences - Quaterly Results

14 Aug 2025 Evaluate
The revenue for the June 2025 quarter is pegged at Rs. 235.84 millions, about 5.29% up against Rs. 223.99 millions recorded during the year-ago period.Net profit of the cmpany stood at Rs. 6.04 millions for the quarter ended June 2025 a decline of -58.00% from Rs. 14.38 millions  in the same quarter last year.Operating Profit reported a sharp decline to 33.73 millions from 37.89 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 235.84 223.99 5.29 235.84 223.99 5.29 1189.21 1048.77 13.39
Other Income 8.47 0.83 920.48 8.47 0.83 920.48 13.20 16.42 -19.61
PBIDT 33.73 37.89 -10.98 33.73 37.89 -10.98 215.70 11.59 1761.09
Interest 17.47 11.08 57.67 17.47 11.08 57.67 45.57 50.50 -9.76
PBDT 16.26 26.81 -39.35 16.26 26.81 -39.35 170.13 -38.91 -537.24
Depreciation 9.35 8.98 4.12 9.35 8.98 4.12 33.79 32.92 2.64
PBT 6.91 17.83 -61.25 6.91 17.83 -61.25 136.34 -71.83 -289.81
TAX 0.87 3.45 -74.78 0.87 3.45 -74.78 40.22 -18.75 -314.51
Deferred Tax 0.87 0.48 81.25 0.87 0.48 81.25 40.22 -18.75 -314.51
PAT 6.04 14.38 -58.00 6.04 14.38 -58.00 96.12 -53.08 -281.09
Equity 47.31 47.31 0.00 47.31 47.31 0.00 47.31 47.31 0.00
PBIDTM(%) 14.30 16.92 -15.45 14.30 16.92 -15.45 18.14 1.11 1541.31
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..